2m 2m 2m 2m 2m 2m 2m
RIGEL PHARM (RIGL)
NASDAQ
$45.90+$0.005 (+0.01%)
Price as of Aug 21, 2026 7:54 PM EDT- $857.2MMarket Cap
- 10.58%1-Year Change
- BiotechnologyIndustry
RIGEL PHARM (RIGL)
$45.90+$0.005 (+0.01%)
RIGL | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $45.89 | ||
Change | +$0.64 (+1.41%) | ||
Open | $45.74 | ||
High | $46.49 | ||
Low | $45.00 | ||
Previous Close | $45.25 | ||
Volume | 322,086 | ||
30-Day Average Volume | 327,947 | ||
1-Week Change | 7.77% | ||
1-Month Change | 16.74% | ||
1-Year Change | 10.58% | ||
3-Year Change | 279.26% | ||
5-Year Change | 25.73% | ||
Fundamentals | |||
Shares Outstanding | 18.7M | ||
Total Assets | $521.1M | ||
Market Cap | $857.2M | ||
Enterprise Value | $835.6M | ||
Period: QTR TTM FY | |||
Revenue | $67.0M | ||
Net Income | $17.3M | ||
Free Cash Flow | $30.7M | ||
EBIT | $24.4M | ||
EBITDA | $25.2M | ||
Net Working Capital | $89.9M | ||
EPS | $0.88 | ||
Enterprise Value/EBITDA | 33 | ||
Enterprise Value/Revenue | 12 | ||
P/B | 2 | ||
P/E | 52 | ||
PEG | 1 | ||
Price/Free Cash Flow | 28 | ||
Price/Operating Cash Flow | 28 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 10 | ||
Last Split Date | 06/27/2024 | ||
Earnings & Revenue